- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05300295
Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)
October 20, 2022 updated by: University of Minnesota
Evaluation of a Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)
The purpose of this pilot project is to evaluate the feasibility of a mentorship program for adolescents with autism spectrum disorder (ASD).
Data will be collected from adolescents with ASD and their parents/guardians.
Study findings will be used to inform further development of the mentoring program for individuals with ASD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of autism spectrum disorder (ASD)
- Age 14-18
- Participants in the mentoring program.
- Participants must have fluent language and will speak and understand English.
- Participants must be able to commit to providing evaluation data.
Exclusion Criteria:
- Have an intellectual disability (IQ under 70)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mentoring Program
The Autism Mentorship Program is a psychosocial intervention that pairs adults and adolescents with autism spectrum disorder (ASD) in one-to-one mentoring relationships.
AMP involves weekly meetings in an afterschool setting and targets the socio-emotional health and social connectedness of adolescents and adults with ASD.
|
The Autism Mentorship Program is a psychosocial intervention that pairs adults and adolescents with autism spectrum disorder (ASD) in one-to-one mentoring relationships.
AMP involves weekly meetings in an afterschool setting and targets the socio-emotional health and social connectedness of adolescents and adults with ASD.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Sessions Attended
Time Frame: within 30 days of the intervention end, up to 10 months
|
Median count of completed session visits
|
within 30 days of the intervention end, up to 10 months
|
Participant Program Satisfaction Scores
Time Frame: within 30 days of the intervention end, up to 10 months
|
Average program satisfaction score; range = 1-5; higher scores are better
|
within 30 days of the intervention end, up to 10 months
|
Mentoring Relationship Quality
Time Frame: within 30 days of the intervention end, up to 10 months
|
Average quality of the mentoring relationship score; range = 1-5; higher scores are better
|
within 30 days of the intervention end, up to 10 months
|
Child Behavior Checklist Scores (Internalizing Subscale)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Parent-completed assessment of child's internalizing behavior; T scores for the internalizing subscale range 0-100 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Child Behavior Checklist Scores (Externalizing Subscale)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Parent-completed assessment of child's externalizing behavior; T scores for the externalizing subscale range 0-100 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth Self-Report Scores (Internalizing Subscale)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth self-reported assessment of internalizing behavior; T scores for the internalizing subscale range 0-100 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth Self-Report Scores (Externalizing Subscale)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth self-reported assessment of externalizing behavior; T scores for the externalizing subscale range 0-100 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Social Skills Improvement System Scores (Social Competence Scale; Parent-report)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Parent-completed assessment of child's social competence; Standard scores for the social competence subscale range 40-160 with lower scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Social Skills Improvement System Scores (Problem Behavior Scale; Parent-report)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Parent-completed assessment of child's problem behavior; Standard scores for the problem behavior subscale range 40-160 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Social Skills Improvement System Scores (Social Competence Scale; Youth-report)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth self-reported assessment of social competence; Standard scores for the social competence subscale range 40-160 with lower scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Social Skills Improvement System Scores (Problem Behavior Scale; Youth-report)
Time Frame: at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Youth self-reported assessment of problem behavior; Standard scores for the problem behavior subscale range 40-160 with higher scores being worse
|
at pre-intervention (within 30 days of intervention start) and post-intervention (within 30 days of intervention end), up to 10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lindsey Weiler, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Actual)
May 31, 2020
Study Completion (Actual)
May 31, 2020
Study Registration Dates
First Submitted
February 24, 2022
First Submitted That Met QC Criteria
March 18, 2022
First Posted (Actual)
March 29, 2022
Study Record Updates
Last Update Posted (Actual)
October 21, 2022
Last Update Submitted That Met QC Criteria
October 20, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003954
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Mentoring Program
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH); Big Brothers Big Sisters of Metropolitan...Completed
-
University of WashingtonNational Institute for Occupational Safety and Health (NIOSH/CDC); The Center...Active, not recruitingMental Stress | Work Related Stress | Work-related Injury | Work-Related Condition | Harassment, Non-Sexual | Harassment, Sexual | Bullying, WorkplaceUnited States
-
Columbia UniversityCompleted
-
Eunice Kennedy Shriver National Institute of Child...CompletedHealth Behavior | Adolescent Behavior | HIV SeronegativityUnited States
-
Samsung Medical CenterCompletedType 1 DiabetesKorea, Republic of
-
Gazi UniversityCompleted
-
Texas A&M UniversityAmerican Heart AssociationRecruitingCardiovascular Diseases | Physical Activity | NutritionUnited States
-
Wake Forest University Health SciencesPatient-Centered Outcomes Research Institute; Atrium Health Levine Cancer InstituteCompletedSickle Cell DiseaseUnited States
-
University of Illinois at ChicagoLaura and John Arnold Foundation; Big Brothers Big Sisters of America; Herrera... and other collaboratorsActive, not recruitingJuvenile Delinquency | CrimeUnited States
-
Karabuk UniversityCompletedMentoring | Comfort | Medication AdministrationTurkey